These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8535021)

  • 1. [Prediction of carboplatin clearance from morphological and biological patient characteristics].
    Chatelut E; Dezeuze A; Lavit M; Chevreau C; Pujol A; Boneu A; Roché H; Houin G; Bugat R; Canal P
    Bull Cancer; 1995 Nov; 82(11):946-53. PubMed ID: 8535021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of carboplatin clearance from standard morphological and biological patient characteristics.
    Chatelut E; Canal P; Brunner V; Chevreau C; Pujol A; Boneu A; Roché H; Houin G; Bugat R
    J Natl Cancer Inst; 1995 Apr; 87(8):573-80. PubMed ID: 7752255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of carboplatin clearance calculated by patient characteristics or 24-hour creatinine clearance: a comparison of the performance of three formulae.
    Okamoto H; Nagatomo A; Kunitoh H; Kunikane H; Watanabe K
    Cancer Chemother Pharmacol; 1998; 42(4):307-12. PubMed ID: 9744776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flat dosing of carboplatin is justified in adult patients with normal renal function.
    Ekhart C; de Jonge ME; Huitema AD; Schellens JH; Rodenhuis S; Beijnen JH
    Clin Cancer Res; 2006 Nov; 12(21):6502-8. PubMed ID: 17085665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Difference of carboplatin clearance estimated by the Cockroft-Gault, Jelliffe, Modified-Jelliffe, Wright or Chatelut formula.
    Nagao S; Fujiwara K; Imafuku N; Kagawa R; Kozuka Y; Oda T; Maehata K; Ishikawa H; Koike H; Aotani E; Kohno I
    Gynecol Oncol; 2005 Nov; 99(2):327-33. PubMed ID: 16005943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population pharmacokinetics of carboplatin in children.
    Chatelut E; Boddy AV; Peng B; Rubie H; Lavit M; Dezeuze A; Pearson AD; Roché H; Robert A; Newell DR; Canal P
    Clin Pharmacol Ther; 1996 Apr; 59(4):436-43. PubMed ID: 8612389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carboplatin pharmacokinetics in children: the development of a pediatric dosing formula. The United Kingdom Children's Cancer Study Group.
    Newell DR; Pearson AD; Balmanno K; Price L; Wyllie RA; Keir M; Calvert AH; Lewis IJ; Pinkerton CR; Stevens MC
    J Clin Oncol; 1993 Dec; 11(12):2314-23. PubMed ID: 8246021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of predictive formulae for glomerular filtration rate for carboplatin dosing in gynecological malignancies.
    de Lemos ML; Hsieh T; Hamata L; Levin A; Swenerton K; Djurdjev O; Vu T; Hu F; Conklin J; Malfair Taylor SC
    Gynecol Oncol; 2006 Dec; 103(3):1063-9. PubMed ID: 16875719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carboplatin dosage: prospective evaluation of a simple formula based on renal function.
    Calvert AH; Newell DR; Gumbrell LA; O'Reilly S; Burnell M; Boxall FE; Siddik ZH; Judson IR; Gore ME; Wiltshaw E
    J Clin Oncol; 2023 Oct; 41(28):4453-4454. PubMed ID: 37757592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cystatin C as a new covariate to predict renal elimination of drugs: application to carboplatin.
    Thomas F; Séronie-Vivien S; Gladieff L; Dalenc F; Durrand V; Malard L; Lafont T; Poublanc M; Bugat R; Chatelut E
    Clin Pharmacokinet; 2005; 44(12):1305-16. PubMed ID: 16372828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of low-dose carboplatin and applicability of a method of calculation for estimating individual drug clearance.
    Etienne MC; Leger F; Pivot X; Chatelut E; Bensadoun RJ; Guardiola E; Renée N; Magné N; Canal P; Milano G
    Ann Oncol; 2003 Apr; 14(4):643-7. PubMed ID: 12649114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A universal formula based on cystatin C to perform individual dosing of carboplatin in normal weight, underweight, and obese patients.
    Schmitt A; Gladieff L; Lansiaux A; Bobin-Dubigeon C; Etienne-Grimaldi MC; Boisdron-Celle M; Serre-Debauvais F; Pinguet F; Floquet A; Billaud E; Le Guellec C; Penel N; Campone M; Largillier R; Capitain O; Fabbro M; Houede N; Medioni J; Bougnoux P; Lochon I; Chatelut E
    Clin Cancer Res; 2009 May; 15(10):3633-9. PubMed ID: 19401344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extension of the Calvert formula to patients with severe renal insufficiency.
    Oguri T; Shimokata T; Ito I; Yasuda Y; Sassa N; Nishiyama M; Hamada A; Hasegawa Y; Ando Y
    Cancer Chemother Pharmacol; 2015 Jul; 76(1):53-9. PubMed ID: 25957958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjustment of creatinine clearance improves accuracy of Calvert's formula for carboplatin dosing.
    Ando Y; Minami H; Saka H; Ando M; Sakai S; Shimokata K
    Br J Cancer; 1997; 76(8):1067-71. PubMed ID: 9376268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of formulae based estimates of glomerular filtration rate for carboplatin dosing in stage 1 seminoma.
    Shepherd ST; Gillen G; Morrison P; Forte C; Macpherson IR; White JD; Mark PB
    Eur J Cancer; 2014 Mar; 50(5):944-52. PubMed ID: 24445148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromium-51-EDTA clearance in adults with a single-plasma sample.
    Mårtensson J; Groth S; Rehling M; Gref M
    J Nucl Med; 1998 Dec; 39(12):2131-7. PubMed ID: 9867156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement of the Cockcroft-Gault equation for predicting glomerular filtration in cancer patients.
    Martin L; Chatelut E; Boneu A; Rostaing L; Roussilhes C; Caselles O; Canal P
    Bull Cancer; 1998 Jul; 85(7):631-6. PubMed ID: 9752271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of carboplatin administered with lobradimil to pediatric patients with brain tumors.
    Warren K; Gervais A; Aikin A; Egorin M; Balis FM
    Cancer Chemother Pharmacol; 2004 Sep; 54(3):206-12. PubMed ID: 15156345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of the Calvert formula to determine the optimal carboplatin dosage.
    van Warmerdam LJ; Rodenhuis S; ten Bokkel Huinink WW; Maes RA; Beijnen JH
    J Cancer Res Clin Oncol; 1995; 121(8):478-86. PubMed ID: 7642691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimation of glomerular filtration rate in cancer patients.
    Wright JG; Boddy AV; Highley M; Fenwick J; McGill A; Calvert AH
    Br J Cancer; 2001 Feb; 84(4):452-9. PubMed ID: 11207037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.